Stay updated on Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision history now includes Revision: v3.4.3 and removes Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T18:26:40.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added References and Study Status sections and updated the record to Revision v3.4.2 on 2026-02-05, while removing the old government-funding notice and Revision v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T09:53:04.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice at the top of the page and updated the revision history to v3.4.1, removing the previous v3.4.0 entry.
    Difference
    0.3%
    Check dated 2026-02-04T05:58:00.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI updates to the history page introduce a Show glossary option and color-coded highlights for additions (green) and deletions (red). The revision version was updated to v3.4.0 and the No FEAR Act Data labeling was adjusted.
    Difference
    0.3%
    Check dated 2026-01-28T04:15:01.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.3.4; v3.3.3 was removed, representing a metadata update with no effect on study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:43:11.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 to the Record History and removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T10:21:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.